Literature DB >> 23303188

Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with Parkinson disease in mammalian cells and Drosophila.

Saera Song1, Seoyeon Jang, Jeehye Park, Sunhoe Bang, Sekyu Choi, Kyum-Yil Kwon, Xiaoxi Zhuang, Eunjoon Kim, Jongkyeong Chung.   

Abstract

Mutations in PINK1 (PTEN-induced putative kinase 1) are tightly linked to autosomal recessive Parkinson disease (PD). Although more than 50 mutations in PINK1 have been discovered, the role of these mutations in PD pathogenesis remains poorly understood. Here, we characterized 17 representative PINK1 pathogenic mutations in both mammalian cells and Drosophila. These mutations did not affect the typical cleavage patterns and subcellular localization of PINK1 under both normal and damaged mitochondria conditions in mammalian cells. However, PINK1 mutations in the kinase domain failed to translocate Parkin to mitochondria and to induce mitochondrial aggregation. Consistent with the mammalian data, Drosophila PINK1 mutants with mutations in the kinase domain (G426D and L464P) did not genetically interact with Parkin. Furthermore, PINK1-null flies expressing the transgenic G426D mutant displayed defective phenotypes with increasing age, whereas L464P mutant-expressing flies exhibited the phenotypes at an earlier age. Collectively, these results strongly support the hypothesis that the kinase activity of PINK1 is essential for its function and for regulating downstream Parkin functions in mitochondria. We believe that this study provides the basis for understanding the molecular and physiological functions of various PINK1 mutations and provides insights into the pathogenic mechanisms of PINK1-linked PD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303188      PMCID: PMC3581423          DOI: 10.1074/jbc.M112.430801

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations.

Authors:  Y Hatano; K Sato; B Elibol; H Yoshino; Y Yamamura; V Bonifati; H Shinotoh; M Asahina; S Kobayashi; A R Ng; R L Rosales; S Hassin-Baer; Y Shinar; C S Lu; H C Chang; Y H Wu-Chou; F B Ataç; T Kobayashi; T Toda; Y Mizuno; N Hattori
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

2.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

Authors:  Yufeng Yang; Stephan Gehrke; Yuzuru Imai; Zhinong Huang; Yingshi Ouyang; Ji-Wu Wang; Lichuan Yang; M Flint Beal; Hannes Vogel; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

Review 3.  Parkinson's disease. Second of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

4.  Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

Authors:  J W Langston; P A Ballard
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

5.  PINK1 (PARK6) associated Parkinson disease in Ireland.

Authors:  D G Healy; P M Abou-Sleiman; J M Gibson; O A Ross; S Jain; S Gandhi; D Gosal; M M K Muqit; N W Wood; T Lynch
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

6.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

Authors:  W J Nicklas; I Vyas; R E Heikkila
Journal:  Life Sci       Date:  1985-07-01       Impact factor: 5.037

7.  Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation.

Authors:  Jügen Prestel; Klaus Gempel; Till-Karsten Hauser; Katherine Schweitzer; Holger Prokisch; Uwe Ahting; Dirk Freudenstein; Eva Bueltmann; Thomas Naegele; Daniela Berg; Thomas Klopstock; Thomas Gasser
Journal:  J Neurol       Date:  2008-02-21       Impact factor: 4.849

8.  Novel PINK1 mutations in early-onset parkinsonism.

Authors:  Yasuko Hatano; Yuanzhe Li; Kenichi Sato; Shuichi Asakawa; Yasuhiro Yamamura; Hiroyuki Tomiyama; Hiroyo Yoshino; Masato Asahina; Susumu Kobayashi; Sharon Hassin-Baer; Chin-Song Lu; Arlene R Ng; Raymond L Rosales; Nobuyoshi Shimizu; Tatsushi Toda; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

9.  Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease.

Authors:  Ryuya Kumazawa; Hiroyuki Tomiyama; Yuanzhe Li; Yoko Imamichi; Manabu Funayama; Hiroyo Yoshino; Fusako Yokochi; Toshihiro Fukusako; Yasushi Takehisa; Kenichi Kashihara; Tomoyoshi Kondo; Bulent Elibol; Sevasti Bostantjopoulou; Tatsushi Toda; Hirohide Takahashi; Fumihito Yoshii; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Arch Neurol       Date:  2008-06

10.  PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons.

Authors:  Alison Wood-Kaczmar; Sonia Gandhi; Zhi Yao; Andrey Y Abramov; Andrey S Y Abramov; Erik A Miljan; Gregory Keen; Lee Stanyer; Iain Hargreaves; Kristina Klupsch; Emma Deas; Julian Downward; Louise Mansfield; Parmjit Jat; Joanne Taylor; Simon Heales; Michael R Duchen; David Latchman; Sarah J Tabrizi; Nicholas W Wood
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  27 in total

1.  A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.

Authors:  Nicholas T Hertz; Amandine Berthet; Martin L Sos; Kurt S Thorn; Al L Burlingame; Ken Nakamura; Kevan M Shokat
Journal:  Cell       Date:  2013-08-15       Impact factor: 41.582

2.  PINK1 Inhibits Local Protein Synthesis to Limit Transmission of Deleterious Mitochondrial DNA Mutations.

Authors:  Yi Zhang; Zong-Heng Wang; Yi Liu; Yong Chen; Nuo Sun; Marjan Gucek; Fan Zhang; Hong Xu
Journal:  Mol Cell       Date:  2019-02-13       Impact factor: 17.970

3.  PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

Authors:  Cristina Guardia-Laguarta; Yuhui Liu; Knut H Lauritzen; Hediye Erdjument-Bromage; Brittany Martin; Theresa C Swayne; Xuejun Jiang; Serge Przedborski
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

Review 4.  Autophagosome dynamics in neurodegeneration at a glance.

Authors:  Yvette C Wong; Erika L F Holzbaur
Journal:  J Cell Sci       Date:  2015-04-01       Impact factor: 5.285

Review 5.  Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity.

Authors:  Ziyan Zhang; Mahfuzur Miah; Megan Culbreth; Michael Aschner
Journal:  Neurochem Res       Date:  2016-02-11       Impact factor: 3.996

Review 6.  The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity.

Authors:  David N Hauser; Christopher T Primiani; Mark R Cookson
Journal:  Curr Protein Pept Sci       Date:  2017       Impact factor: 3.272

Review 7.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

Review 8.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

9.  Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.

Authors:  Adam L Orr; Florentine U Rutaganira; Daniel de Roulet; Eric J Huang; Nicholas T Hertz; Kevan M Shokat; Ken Nakamura
Journal:  Neurochem Int       Date:  2017-04-20       Impact factor: 3.921

Review 10.  Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues.

Authors:  Britney N Lizama; Amy M Palubinsky; BethAnn McLaughlin
Journal:  Neurochem Int       Date:  2017-08-26       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.